Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28476 - 28500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	IRX5	10265	upregulated	Cytarabine results in increased expression of IRX5 mRNA	16q12.2	A21886
Cytarabine	Approved Investigational	ITGB5	3693	downregulated	Cytarabine results in decreased expression of ITGB5 mRNA	3q21.2	A21886
Cytarabine	Approved Investigational	ITM2C	81618	downregulated	Cytarabine results in decreased expression of ITM2C mRNA	2q37.1	A21886
Cytarabine	Approved Investigational	JAM2	58494	upregulated	Cytarabine results in increased expression of JAM2 mRNA	21q21.3	A21886
Cytarabine	Approved Investigational	JUN	3725	upregulated	Cytarabine results in increased expression of JUN mRNA	1p32.1	A21887
Cytarabine	Approved Investigational	KANK4	163782	downregulated	Cytarabine results in decreased expression of KANK4 mRNA	1p31.3	A21886
Cytarabine	Approved Investigational	KCNN2	3781	downregulated	Cytarabine results in decreased expression of KCNN2 mRNA	5q22.3	A21886
Cytarabine	Approved Investigational	KCTD12	115207	downregulated	Cytarabine results in decreased expression of KCTD12 mRNA	13q22.3	A21886
Cytarabine	Approved Investigational	KDELR3	11015	downregulated	Cytarabine results in decreased expression of KDELR3 mRNA	22q13.1	A21886
Cytarabine	Approved Investigational	KIAA1671	85379	downregulated	Cytarabine results in decreased expression of KIAA1671 mRNA	22q11.23	A21886
Cytarabine	Approved Investigational	KIF15	56992	upregulated	Cytarabine results in increased expression of KIF15 mRNA	3p21.31	A21886
Cytarabine	Approved Investigational	KLHL41	10324	downregulated	Cytarabine results in decreased expression of KLHL41 mRNA	2q31.1	A21886
Cytarabine	Approved Investigational	KLK6	5653	downregulated	Cytarabine results in decreased expression of KLK6 mRNA	19q13.3	A21886
Cytarabine	Approved Investigational	KPNA2	3838	downregulated	Cytarabine results in decreased expression of KPNA2 mRNA	17q24.2	A20666
Cytarabine	Approved Investigational	KRT19	3880	downregulated	Cytarabine results in decreased expression of KRT19 mRNA	17q21.2	A21886
Cytarabine	Approved Investigational	KRT24	192666	downregulated	Cytarabine results in decreased expression of KRT24 mRNA	17q21.2	A21886
Cytarabine	Approved Investigational	KRT8	3856	downregulated	Cytarabine results in decreased expression of KRT8 mRNA	12q13.13	A21886
Cytarabine	Approved Investigational	KYNU	8942	downregulated	Cytarabine results in decreased expression of KYNU mRNA	2q22.2	A21886
Cytarabine	Approved Investigational	LBH	81606	downregulated	Cytarabine results in decreased expression of LBH mRNA	2p23.1	A21886
Cytarabine	Approved Investigational	LEPR	3953	downregulated	Cytarabine results in decreased expression of LEPR mRNA	1p31.3	A21886
Cytarabine	Approved Investigational	LHFP	10186	upregulated	Cytarabine results in increased expression of LHFP mRNA	13q13.3-q14.11	A21886
Cytarabine	Approved Investigational	LIMCH1	22998	upregulated	Cytarabine results in increased expression of LIMCH1 mRNA	4p13	A21886
Cytarabine	Approved Investigational	LINC00305	221241	downregulated	Cytarabine results in decreased expression of LINC00305 mRNA	18q22.1	A21886
Cytarabine	Approved Investigational	LINC00312	29931	downregulated	Cytarabine results in decreased expression of LINC00312 mRNA	3p25.3	A21886
Cytarabine	Approved Investigational	LMCD1	29995	downregulated	Cytarabine results in decreased expression of LMCD1 mRNA	3p25.3	A21886

Displaying entries 28476 - 28500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability